Candesartan and carvedilol for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin

Candesartan and carvedilol for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin

Abstract Background There is no proven primary preventive strategy for doxorubicin‐induced subclinical cardiotoxicity (DISC), especially among patients without a cardiovascular (CV) risk. We investigated the primary preventive effect on DISC of the concomitant use of angiotensin receptor blockers (A...

Full description

Bibliographic Details
Main Authors:	Myunhee Lee, Woo‐Baek Chung, Ji‐eun Lee, Chan‐Seok Park, Woo‐Chan Park, Byung‐Joo Song, Ho‐Joong Youn
Format:	Article
Language:	English
Published:	Wiley 2021-06-01
Series:	Cancer Medicine
Subjects:	adrenergic beta‐antagonists angiotensin receptor antagonists anthracyclines breast cancer cardiomyopathies prevention
Online Access:	https://doi.org/10.1002/cam4.3956

Similar Items

Utilization of evidence-based treatment in elderly patients with chronic heart failure: using Korean Health Insurance claims database
by: Kim Ju-Young, et al.
Published: (2012-07-01)

Cardioprotective role of carvedilol in patients on chemotherapy: systematic review and meta-analysis of randomized clinical trials
by: Lucía Florio Legnani, et al.
Published: (2018-01-01)

"Oral ascorbic acid in combination with beta blockers in prevention of atrial fibrillation after Coronary Artery Bypass Graft "
by: Mousavi M, et al.
Published: (2007-04-01)

A Prospective, Multicenter, Open-Label Study of Dose Escalation Therapy in Male Patients With Nocturia Refractory to 0.2-mg Tamsulosin Monotherapy
by: Ho Song Yu, et al.
Published: (2019-12-01)

Efficacy of low-dose spironolactone on top of angiotensin receptor blockade in patients with glomerulonephritis
by: Byung Chul Yu, et al.
Published: (2018-09-01)

Sudden Intraoperative Hyperkalemia during Laparoscopic Radical Nephrectomy in a Patient with Underlying Renal Insufficiency
by: Sung Hoon Jung, et al.
Published: (2018-11-01)

Decatecholaminization and calcium sensitizers in critically ill patients
by: Samad E J Golzari, et al.
Published: (2014-01-01)

Efeito do carvedilol na prevenção da cardiotoxicidade por antraciclinas: estudo randomizado, duplo-cego, placebo controlado (CECCY Trial)
by: Mônica Samuel Avila Grinberg
Published: (2018)

Efeito do carvedilol na prevenção da cardiotoxicidade por antraciclinas: estudo randomizado, duplo-cego, placebo controlado (CECCY Trial)
by: Grinberg, Mônica Samuel Avila
Published: (2018)

Computed Tomographic Angiography Assessment of Epicardial Coronary Vasoreactivity for Early Detection of Doxorubicin-Induced Cardiotoxicity
by: Attila Feher, MD, PhD, et al.
Published: (2020-06-01)

Effects of Terazosin and Tolterodine on Ureteral Stent Related Symptoms: A Double-Blind Placebo-Controlled Randomized Clinical Trial
by: Ali Tehranchi, et al.
Published: (2013-12-01)

Efficacy and safety of low-dose anticholinergics to treat men with lower urinary tract symptoms with overactive bladder: a retrospective study based on real life practice
by: Kyung Kgi Park
Published: (2013-03-01)

The Effectiveness of Silodosin for Nocturnal Polyuria in Elderly Men With Benign Prostatic Hyperplasia: A Multicenter Study
by: Young Won Kim, et al.
Published: (2015-09-01)

Cognitive Function and Urologic Medications for Lower Urinary Tract Symptoms
by: Yeon Joo Kim, et al.
Published: (2020-09-01)

Efficacy and safety of silodosin in the treatment of lower urinary tract symptoms in elderly men taking antihypertensive medications
by: Woo Suk Choi, et al.
Published: (2017-09-01)

Research progress of intraoperative floppy iris syndrome during phacoemulsification
by: Mei-Yan Xin, et al.
Published: (2016-06-01)

Clinical Outcome in Male Patients With Detrusor Overactivity With Impaired Contractility
by: Shuo Liu, et al.
Published: (2014-09-01)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
by: Hyun Woo Lee, et al.
Published: (2021-03-01)

Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series
by: Sarju Ganatra, et al.
Published: (2019-01-01)

Effects of prostatic inflammation on LUTS and alpha blocker treatment outcomes
by: Ha Na Lee, et al.
Published: (2014-06-01)

Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat
by: Alireza Komaki, et al.
Published: (2014-07-01)

Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans
by: Caroline J. Zeiss, et al.
Published: (2019-08-01)

Resveratrol significantly improves cell survival in comparison to dexrazoxane and carvedilol in a h9c2 model of doxorubicin induced cardiotoxicity
by: David S. Monahan, et al.
Published: (2021-08-01)

Preventive effects of tamsulosin for postoperative urinary retention after lower limb arthroplasty: A randomized controlled study
by: Chang Il Choi, et al.
Published: (2021-09-01)

Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
by: Shayan Moazeni, et al.
Published: (2017-05-01)

Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension
by: Jinwoo Lee, et al.
Published: (2021-03-01)

Detection of subclinical anthracycline induced cardiotoxicity in breast cancer survivors
by: Preety Negi, et al.
Published: (2014-01-01)

Efficacy of an Alpha-Blocker for the Treatment of Nonneurogenic Voiding Dysfunction in Women: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial
by: Young-Suk Lee, et al.
Published: (2018-03-01)

Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
by: Hui-Min Hu, et al.
Published: (2018-01-01)

Analysis of Models of Doxorubicin-Induced Cardiomyopathy in Rats and Mice. A Modern View From the Perspective of the Pathophysiologist and the Clinician
by: Ekaterina Yu Podyacheva, et al.
Published: (2021-06-01)

Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments
by: Dong Hyuk Kang, et al.
Published: (2011-12-01)

Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
by: Raquel Araujo-Gutierrez, et al.
Published: (2021-01-01)

The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study
by: Byung Hoon Kim, et al.
Published: (2016-03-01)

The Noradrenergic System is Partly Involved in Resveratrol Antidepressant and Anti-Obsessive Like Effects in Mice Model
by: Azadeh Mesripour*, et al.
Published: (2021-06-01)

Golgi localized β1-adrenergic receptors stimulate Golgi PI4P hydrolysis by PLCε to regulate cardiac hypertrophy
by: Craig A Nash, et al.
Published: (2019-08-01)

Salivary Protein Components and Oral Health in Patients Undergoing Therapy with Beta Adrenegic Agonist and Antagonist
by: Tahani A Al–Sandook, et al.
Published: (2008-08-01)

Atenolol prevents the formation of expansive hematoma after rhytidoplasty
by: Amanda Castilho Moreira, et al.

Hypertension and Male Fertility
by: David Guo, et al.
Published: (2017-08-01)

Failure of intravenous lipid emulsion in treatment of cardiotoxicity caused by mixed overdose including dihydropyridine calcium channel blockers
by: Jović-Stošić Jasmina, et al.
Published: (2016-01-01)

Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
by: Timothy N. McOwan, et al.
Published: (2020-05-01)